March 29, 2023 Uncategorized BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article Read More
March 22, 2023 Uncategorized Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article Read More
March 14, 2023 Uncategorized CORRECTION – BetterLife Closes $1,857,143 of Private Placement Read More
March 10, 2023 Uncategorized BetterLife Files Amended and Restated Offering Document for Offering of Units Read More
March 9, 2023 Uncategorized Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders.” Read More